Senate Hearing on Pandemic Discusses Reshoring Pharma, PPE
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
Elizabeth Warren Gets it Right on Pharmaceutical Manufacturing
It’s time for Elizabeth Warren to re-introduce her pharmaceutical supply chain legislation.
CPA Conference Day 1: Making Generic Pharmaceuticals A National Security Imperative
Healthcare panelist and Phlow CEO Eric Edwards on what needs to be done to make more pharmaceutical drugs here. Most of them are coming in from Europe, India and…increasingly…China.
America’s Dependence on China for Essential Medicines a Growing Safety Threat
Rosemary Gibson chairs the healthcare committee of the Coalition for a Prosperous America. She is the author of “China Rx: Exposing the Risks of America’s
Industry and Union Coalition Outlines Policy Recommendations in Letters to President Biden, Congressional Leaders
WASHINGTON—A broad coalition of industry organizations and labor unions, representing a broad spectrum of manufacturers and workers who stepped up to make essential PPE and
Heparin Shortages Due to a Dependence on China. Why American Cattle is the Solution.
By Kenneth Rapoza, CPA Industry Analyst Why are we dependent on China’s pig population for a critical animal source material used in making heparin? Bovine
The U.S. needs to support American-made medicines
CPA’s Take: CivicaRX CEO Martin VanTrieste explains why it is essential, and achievable to reshore pharmaceutical production to the US. Two years ago, a group
Kodak to Produce Drug Ingredients in U.S. Thanks to Defense Production Act
CPA’s take: It’s great to see the Trump administration invoking the DPA to lend Kodak some serious money, great to see a historic US company getting
Industry Group Coalition Supports Reshoring PPE Manufacturing
The AFL-CIO, USW, and 19 other groups released a joint statement on bringing PPE manufacturing back to the States. On July 20, a coalition of
